Skip to main content

Advertisement

Table 3 Total cholesterol, triglycerides, LDL, HDL concentrations (mg/dL), total cholesterol: LDL, total cholesterol: HDL and LDL: HDL ratios of groups 1 and 2

From: Anti-hyperglycaemic effects of herbal porridge made of Scoparia dulcis leaf extract in diabetics – a randomized crossover clinical trial

  Study period 1 Study period 2
TC (mg/dL) Test (mean ± SEM) Control (mean ± SEM)
  0 week 12 weeks 14 weeks 26 weeks
Group 1a 228 ± 12 235 ± 13 246 ± 10 224 ± 10
  Control (mean ± SEM) Test (mean ± SEM)
  0 week 12 weeks 14 weeks 26 weeks
Group 2b 211 ± 14 233 ± 10 224 ± 14 232 ± 11
TG (mg/dL) Test (mean ± SEM) Control (mean ± SEM)
Group 1a 0 week 12 weeks 14 weeks 26 weeks
123 ± 9 139 ± 15 182 ± 20 175 ± 23
Control (mean ± SEM) Test (mean ± SEM)
Group 2b 0 week 12 weeks 14 weeks 26 weeks
142 ± 15 185 ± 15 171 ± 16 164 ± 19
LDL (mg/dL) Test (mean ± SEM) Control (mean ± SEM)
Group 1a 0 week 12 weeks 14 weeks 26 weeks
163 ± 11 168 ± 11 169 ± 10 151 ± 8
Control (mean ± SEM) Test (mean ± SEM)
Group 2b 0 week 12 weeks 14 weeks 26 weeks
137 ± 14 152 ± 9 147 ± 11 153 ± 10
HDL (mg/dL) Test (mean ± SEM) Control (mean ± SEM)
Group 1a 0 week 12 weeks 14 weeks 26 weeks
39.5 ± 2.1 39.0 ± 1.8 40.3 ± 1.9 37.3 ± 2.0
Control (mean ± SEM) Test (mean ± SEM)
Group 2b 0 week 12 weeks 14 weeks 26 weeks
43.9 ± 2.8 42.5 ± 2.1 42.8 ± 2.8 44.8 ± 2.3
  Study Period 1 Study Period 2
TC:LDL Test (mean ± SEM) Control (mean ± SEM)
  0 week 12 weeks 14 weeks 26 weeks
Group 1a 1.43 ± 0.04 1.49 ± 0.05 1.42 ± 0.03 1.47 ± 0.03
  Control (mean ± SEM) Test (mean ± SEM)
  0 week 12 weeks 14 weeks 26 weeks
Group 2b 1.63 ± 0.06 1.56 ± 0.03 1.56 ± 0.05 1.55 ± 0.04
TC:HDL Test (mean ± SEM) Control (mean ± SEM)
  0 week 12 weeks 14 weeks 26 weeks
Group 1a 6.28 ± 0.40 5.69 ± 0.50 3.95 ± 0.28 4.20 ± 0.32
  Control (mean ± SEM) Test (mean ± SEM)
  0 week 12 weeks 14 weeks 26 weeks
Group 2b 5.22 ± 0.54 5.62 ± 0.34 5.50 ± 0.38 5.53 ± 0.43
LDL:HDL Test (mean ± SEM) Control (mean ± SEM)
  0 week 12 weeks 14 weeks 26 weeks
Group 1a 4.33 ± 0.35 4.28 ± 0.28 6.29 ± 0.39 5.89 ± 0.37
  Control (mean ± SEM) Test (mean ± SEM)
  0 week 12 weeks 14 weeks 26 weeks
Group 2b 3.38 ± 0.48 3.69 ± 0.28 3.62 ± 0.32 3.71 ± 0.36
AI Test (mean ± SEM) Control (mean ± SEM)
  0 week 12 weeks 14 weeks 16 weeks
Group 1a 0.49 ± 0.05 0.54 ± 0.06 0.61 ± 0.06 0.64 ± 0.7
  Control (mean ± SEM) Test (mean ± SEM)
  0 week 12 weeks 14 weeks 16 weeks
Group 2b 0.50 ± 0.06 0.62 ± 0.04 0.59 ± 0.05 0.54 ± 0.06
  1. Week 0 and week 14 indicates the basal serum parameters as those values have been obtained prior to the intervention
  2. an = 16, bn = 19; SEM = standard error of mean; Superscripts indicate a significant difference in a parameter when compared to basal value within a study period (p < 0.05)